2019
DOI: 10.1007/s00520-019-04999-4
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review examining nutrition support interventions in patients with incurable cancer

Abstract: Recent guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) have advocated increased attention to nutritional support in all patients with cancer: however, little is known about the optimal type of nutritional intervention. The aim of this review was to assess the current evidence for nutrition support in patients with incurable cancer. Methods: This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. EM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
38
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(40 citation statements)
references
References 32 publications
1
38
0
1
Order By: Relevance
“…Although cancer cachexia cannot be treated with nutritional therapy alone,70,71 optimum nutrition is an important part of any multimodal intervention aimed at increasing energy intake39 and alleviating psychosocial stress 72. In addition, nutritional supplements enriched with n-3 polysaturated fatty acids, such as EPA, might have benefits in cancer cachexia patients 73,74.…”
Section: Resultsmentioning
confidence: 99%
“…Although cancer cachexia cannot be treated with nutritional therapy alone,70,71 optimum nutrition is an important part of any multimodal intervention aimed at increasing energy intake39 and alleviating psychosocial stress 72. In addition, nutritional supplements enriched with n-3 polysaturated fatty acids, such as EPA, might have benefits in cancer cachexia patients 73,74.…”
Section: Resultsmentioning
confidence: 99%
“…emotional functioning, loss of appetite and global QoL) but noted that evidence was weak due to the poor methodological quality of included trials. 30,47 In cancer cachexia, n-3 fatty acids have been studied, particularly for their anti-inflammatory properties, and are available as a component of specialised ONSs, usually also enriched in protein (N3P-ONSs). Several randomised trials have been published on the effects of N3P-ONSs in cancer patients.…”
Section: Dietary Counselling and Onssmentioning
confidence: 99%
“…emotional functioning, loss of appetite and global QoL) but noted that evidence was weak due to the poor methodological quality of included trials. 30 , 47 …”
Section: Nutritional Interventionsmentioning
confidence: 99%
“…Search results were limited to research in the adult population published from developed countries between 1 January 2010 and 1 April 2020 and written in the English language. This specific date range was chosen because past reviews [20][21][22][23][24] have already evaluated nutrition interventions from studies dated previously and because early nutrition intervention specifically is a more modern practice due to evidence-based position papers and clinical guidelines [14][15][16][25][26][27] that have raised awareness and provided guidance for nutrition interventions. Manual searches were also performed on existing systematic reviews and studies recommended for consideration from clinical nutrition experts.…”
Section: Search Strategymentioning
confidence: 99%
“…Multiple nutrition interventions, including dietary counseling or advice, oral nutritional supplements (ONS), and enteral nutrition, have shown positive outcomes in malnourished hospitalized and community-dwelling adults with cancer [17][18][19]. Furthermore, systematic reviews have underscored the strength of evidence of such nutrition interventions on nutrition and health outcomes for oncology patients [20][21][22][23][24]. In addition to the positive effects of nutrition interventions on malnutrition, nutrition interventions have also been documented to improve outcomes such as quality of life (QoL) [18] and possibly survival [19] in cancer patients.…”
Section: Introductionmentioning
confidence: 99%